8-K - Enliven Therapeutics, Inc. (0001672619) (Filer)
Published . Updated .
Filed: 2026-10-14 AccNo: 0001193125-26-421761 Size: 160 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Directly affected
- ELVN Enliven Therapeutics
Named in this report.
Indirectly affected
- SPY SPDR S&P 500
The broad U.S. stock market
- TLT iShares 20+ Year Treasury Bond
Long-term U.S. government bonds
- QQQ Invesco QQQ
Large technology stocks
- GLD SPDR Gold Shares
Gold can move with the broad market
Price reaction, T-5 to T+3
Filed: 2026-10-14 AccNo: 0001193125-26-421761 Size: 160 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 7.01: Regulation F…
Source: sec-edgar
Price since this story was published: Enliven Therapeutics (ELVN)
Since the first closing price after “8-K - Enliven Therapeutics, Inc. (0001672619) (Filer),” Enliven Therapeutics (ELVN) is -0.57%. The S&P 500 fund (SPY) is -0.67% over the same days, a +0.10% difference versus the market.
| Company | When | Move | Status |
|---|---|---|---|
| Enliven Therapeutics (ELVN) | that day | +0.13% | final price |
| Enliven Therapeutics (ELVN) | the next day | -4.99% | final price |
| Enliven Therapeutics (ELVN) | two days later | -1.48% | final price |
| Enliven Therapeutics (ELVN) | three days later | +2.70% | still updating |
| Enliven Therapeutics (ELVN) | three days earlier | +3.97% | final price |
| Enliven Therapeutics (ELVN) | five days earlier | +3.44% | final price |
| GLD | that day | +1.78% | final price |
| GLD | the next day | +1.61% | final price |
| GLD | two days later | +0.98% | final price |
| GLD | three days later | +0.61% | still updating |
| GLD | three days earlier | +1.65% | final price |
| GLD | five days earlier | +0.71% | final price |
| QQQ | that day | -0.11% | final price |
| QQQ | the next day | -2.63% | final price |
| QQQ | two days later | -1.46% | final price |
| QQQ | three days later | -1.78% | still updating |
| QQQ | three days earlier | +2.33% | final price |
| QQQ | five days earlier | +2.54% | final price |
| SPY | that day | +0.28% | final price |
| SPY | the next day | -0.82% | final price |
| SPY | two days later | -0.40% | final price |
| SPY | three days later | -0.22% | still updating |
| SPY | three days earlier | +1.09% | final price |
| SPY | five days earlier | +0.55% | final price |
| TLT | that day | +1.41% | final price |
| TLT | the next day | +1.46% | final price |
| TLT | two days later | +0.74% | final price |
| TLT | three days later | +1.57% | still updating |
| TLT | three days earlier | -1.08% | final price |
| TLT | five days earlier | -1.29% | final price |
Who gains and who loses around Enliven Therapeutics (ELVN)
Companies mentioned with this story
- ELVN Enliven Therapeutics
In “8-K - Enliven Therapeutics, Inc. (0001672619) (Filer),” Enliven Therapeutics (ELVN) is linked, with no stored direction, high confidence. Reason on file: SEC 8-K filing -> direct issuer disclosure -> ELVN
How “8-K - Enliven Therapeutics, Inc. (0001672619) (Filer)” reaches Enliven Therapeutics (ELVN)
The 14 Oct 2026 story “8-K - Enliven Therapeutics, Inc. (0001672619) (Filer)” names Enliven Therapeutics (ELVN) because of this story.
Enliven Therapeutics (ELVN) is on the page because SEC 8-K filing -> direct issuer disclosure -> ELVN
Dates and price levels for Enliven Therapeutics (ELVN)
ELVN traded between 36.96 and 40.27 across 4 sessions. The latest close on file is 38.71.
How solid “8-K - Enliven Therapeutics, Inc. (0001672619) (Filer)” looks
44 out of 100Price not final
“8-K - Enliven Therapeutics, Inc. (0001672619) (Filer)” scores 44 out of 100. The score uses 1 sources, a -4.17% difference versus the S&P 500 (SPY), and 1 linked companies. The price is not final yet.